Search Results - "Lélu, K"

O031 : TG1050, a novel immunotherapeutic to treat chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models by Lélu, K, Evlachev, A, Kratzer, R, Dion, S, Mancini-Bourgine, M, Godon, O, Schmitt, D, Dubois, C, Mériter, J.-F, Schlesinger, Y, Marchand, J.-B, Geist, M, Brandely, R, Findeli, A, Menguy, T, Silvestre, N, Michel, M.-L, Inchauspe, G, Martin, P

Get full text

TG1050, a novel immunotherapeutic for the treatment of chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models by Lélu, K, Evlachev, A, Kratzer, R, Godon, O, Mancini-Bourgine, M, Dion, S, Schmitt, D, Dubois, C, Meritet, J.F, Schlesinger, Y, Marchand, J.B, Geist, M, Brandely, R, Findeli, A, Zhu, R, Menguy, T, Silvestre, N, Michel, M.L, Inchauspé, G, Martin, P

Get full text

A new two-dimensional chromatographic method for separation of saponins from steamed Panax notoginseng by Lelu, Jimmy K., Liu, Qi, Alolga, Raphael N., Fan, Yong, Xiao, Wei-Lie, Qi, Lian-Wen, Li, Ping

“…[Display omitted] •This short communication details a new automated multi-step preparative separation system, known as Sepbox.•Sepbox afforded a quick,…”
Get full text